JP2012505879A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012505879A5 JP2012505879A5 JP2011532044A JP2011532044A JP2012505879A5 JP 2012505879 A5 JP2012505879 A5 JP 2012505879A5 JP 2011532044 A JP2011532044 A JP 2011532044A JP 2011532044 A JP2011532044 A JP 2011532044A JP 2012505879 A5 JP2012505879 A5 JP 2012505879A5
- Authority
- JP
- Japan
- Prior art keywords
- carboxy
- amino
- alkoxycarbonyl
- alkyl
- alkylamino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 27
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 23
- 239000008194 pharmaceutical composition Substances 0.000 claims 22
- 125000003282 alkyl amino group Chemical group 0.000 claims 21
- 125000004663 dialkyl amino group Chemical group 0.000 claims 19
- 125000003545 alkoxy group Chemical group 0.000 claims 15
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 15
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 14
- 125000000217 alkyl group Chemical group 0.000 claims 13
- -1 hydroxy alkoxyalkyl Chemical group 0.000 claims 13
- 125000004181 carboxyalkyl group Chemical group 0.000 claims 7
- 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 claims 6
- 125000004103 aminoalkyl group Chemical group 0.000 claims 6
- 206010002022 amyloidosis Diseases 0.000 claims 6
- 201000010099 disease Diseases 0.000 claims 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
- 125000000278 alkyl amino alkyl group Chemical group 0.000 claims 4
- 125000002947 alkylene group Chemical group 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 4
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 claims 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 4
- 125000004964 sulfoalkyl group Chemical group 0.000 claims 4
- 125000005085 alkoxycarbonylalkoxy group Chemical group 0.000 claims 3
- 125000003418 alkyl amino alkoxy group Chemical group 0.000 claims 3
- 125000002431 aminoalkoxy group Chemical group 0.000 claims 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 125000004984 dialkylaminoalkoxy group Chemical group 0.000 claims 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- ZZOKVYOCRSMTSS-UHFFFAOYSA-N 9h-fluoren-9-ylmethyl carbamate Chemical compound C1=CC=C2C(COC(=O)N)C3=CC=CC=C3C2=C1 ZZOKVYOCRSMTSS-UHFFFAOYSA-N 0.000 claims 2
- 208000023769 AA amyloidosis Diseases 0.000 claims 2
- 208000023761 AL amyloidosis Diseases 0.000 claims 2
- 206010016202 Familial Amyloidosis Diseases 0.000 claims 2
- 208000005531 Immunoglobulin Light-chain Amyloidosis Diseases 0.000 claims 2
- 102000004877 Insulin Human genes 0.000 claims 2
- 108090001061 Insulin Proteins 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- 241001465754 Metazoa Species 0.000 claims 2
- 206010036673 Primary amyloidosis Diseases 0.000 claims 2
- 206010039811 Secondary amyloidosis Diseases 0.000 claims 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims 2
- 125000004442 acylamino group Chemical group 0.000 claims 2
- 125000004945 acylaminoalkyl group Chemical group 0.000 claims 2
- 125000005530 alkylenedioxy group Chemical group 0.000 claims 2
- PUJDIJCNWFYVJX-UHFFFAOYSA-N benzyl carbamate Chemical compound NC(=O)OCC1=CC=CC=C1 PUJDIJCNWFYVJX-UHFFFAOYSA-N 0.000 claims 2
- 125000004057 biotinyl group Chemical group [H]N1C(=O)N([H])[C@]2([H])[C@@]([H])(SC([H])([H])[C@]12[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 claims 2
- 125000005111 carboxyalkoxy group Chemical group 0.000 claims 2
- 125000004966 cyanoalkyl group Chemical group 0.000 claims 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 2
- 230000000642 iatrogenic effect Effects 0.000 claims 2
- 229940125396 insulin Drugs 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- XBXCNNQPRYLIDE-UHFFFAOYSA-M n-tert-butylcarbamate Chemical compound CC(C)(C)NC([O-])=O XBXCNNQPRYLIDE-UHFFFAOYSA-M 0.000 claims 2
- 125000004971 nitroalkyl group Chemical group 0.000 claims 2
- 210000000056 organ Anatomy 0.000 claims 2
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims 2
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- 125000005556 thienylene group Chemical group 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 206010007509 Cardiac amyloidosis Diseases 0.000 claims 1
- 208000023105 Huntington disease Diseases 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 208000024777 Prion disease Diseases 0.000 claims 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 claims 1
- 208000018756 Variant Creutzfeldt-Jakob disease Diseases 0.000 claims 1
- 208000005881 bovine spongiform encephalopathy Diseases 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 239000000872 buffer Substances 0.000 claims 1
- IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 claims 1
- 125000005159 cyanoalkoxy group Chemical group 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 claims 1
- 125000005567 fluorenylene group Chemical group 0.000 claims 1
- 208000017105 hereditary amyloidosis Diseases 0.000 claims 1
- 125000005113 hydroxyalkoxy group Chemical group 0.000 claims 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 1
- 201000008319 inclusion body myositis Diseases 0.000 claims 1
- 206010022437 insomnia Diseases 0.000 claims 1
- 231100000518 lethal Toxicity 0.000 claims 1
- 230000001665 lethal effect Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000005702 oxyalkylene group Chemical group 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0850043-1 | 2008-10-17 | ||
| SE0850043 | 2008-10-17 | ||
| SE0850050-6 | 2008-10-23 | ||
| SE0850050 | 2008-10-23 | ||
| PCT/SE2009/051187 WO2010044743A1 (en) | 2008-10-17 | 2009-10-19 | Novel thiophene compounds for use in theraphy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012505879A JP2012505879A (ja) | 2012-03-08 |
| JP2012505879A5 true JP2012505879A5 (enExample) | 2012-11-29 |
| JP5646495B2 JP5646495B2 (ja) | 2014-12-24 |
Family
ID=42106726
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011532044A Expired - Fee Related JP5646495B2 (ja) | 2008-10-17 | 2009-10-19 | 療法において使用するための新規チオフェン化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8710246B2 (enExample) |
| EP (1) | EP2350042B1 (enExample) |
| JP (1) | JP5646495B2 (enExample) |
| KR (1) | KR101743049B1 (enExample) |
| CN (1) | CN102256959B (enExample) |
| BR (1) | BRPI0920850A2 (enExample) |
| CA (1) | CA2740969C (enExample) |
| ES (1) | ES2551744T3 (enExample) |
| WO (2) | WO2010044744A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012009484A2 (en) | 2010-07-13 | 2012-01-19 | Stc.Unm | Structure, synthesis, and applications for poly (phenylene) ethynylenes (ppes) |
| US9125415B2 (en) | 2011-07-08 | 2015-09-08 | Stc, Unm | Thiophene based oligomers as light activated biocides |
| US9359311B2 (en) | 2011-07-14 | 2016-06-07 | Neuroscios Gmbh | Substituted aromatic oligomers |
| WO2013020096A2 (en) | 2011-08-03 | 2013-02-07 | Stc.Unm | Antimicrobial materials and methods |
| WO2013036196A1 (en) * | 2011-09-07 | 2013-03-14 | Biochromix Ab | Novel thiophene compounds and method for in vivo imaging |
| SE536793C2 (sv) | 2012-07-02 | 2014-08-19 | Richter Life Science Dev Ab | Detektion av kolhydrater |
| US9968698B2 (en) | 2013-11-08 | 2018-05-15 | Stc. Unm | Charged singlet-oxygen sensitizers and oppositely-charged surfactants |
| WO2015138965A1 (en) | 2014-03-14 | 2015-09-17 | Whitten David G | P-phenylene ethynylene compounds as bioactive and detection agents |
| JP6434167B2 (ja) | 2015-01-14 | 2018-12-05 | ジー． ウィッテン，デイヴィッド | 共役高分子電解質およびそれを使用する方法 |
| AU2016331156B2 (en) | 2015-10-01 | 2022-03-03 | Richter Life Science Development Ab | Detection of microbial peptides |
| US10772851B2 (en) | 2017-02-03 | 2020-09-15 | Aaron Kurt Neumann | Treatment and prevention of fungal infections |
| WO2020154623A1 (en) * | 2019-01-24 | 2020-07-30 | Alzeca Biosciences, LLC | Functionalized liposomes for imaging misfolded proteins |
| CN119264384A (zh) * | 2023-07-04 | 2025-01-07 | 宁德时代未来能源(上海)研究院有限公司 | 化合物、钙钛矿太阳能电池和用电装置 |
| CN118724890A (zh) * | 2024-06-05 | 2024-10-01 | 佛山大学 | 一种抗细菌生物膜剂的荧光示踪成像探针分子及其制备方法和应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4861692A (en) * | 1986-12-22 | 1989-08-29 | Fuji Electric Company, Ltd. | Electrophotographic photosensitive material containing thiophene compound |
| JPS63158557A (ja) * | 1986-12-23 | 1988-07-01 | Fuji Electric Co Ltd | 電子写真用感光体 |
| US5747525A (en) * | 1992-02-19 | 1998-05-05 | Industrial Technology Research Institute | Medicinal thiophene compounds |
| JP3885244B2 (ja) | 1994-12-05 | 2007-02-21 | 松下電器産業株式会社 | オリゴチオフェン重合体、及びオリゴチオフェン化合物の製造方法 |
| EP1007035A4 (en) | 1996-11-26 | 2000-11-22 | Purdue Research Foundation | POLYTHIOPHENES AS ANTITUARY AGENTS |
| US6730929B2 (en) | 1999-12-24 | 2004-05-04 | Matsushita Electric Industrial Co., Ltd. | Organic electroluminescent device |
| TW200413009A (en) * | 2002-10-04 | 2004-08-01 | Univ Pennsylvania | Biphenyls and fluorenes as imaging agents in alzheimer's disease |
| EP1605733A4 (en) * | 2003-03-14 | 2009-08-05 | Semiconductor Energy Lab | CONJUGATED MOLECULE, ELECTROLUMINESCENT ELEMENT USING THE SAME, AND ELECTRONIC APPARATUS USING THE LIGHT EMITTING ELEMENT |
| SE0401219D0 (sv) * | 2004-05-10 | 2004-05-10 | Biochromix Ab | Metoder för detektera konformationsförändringar eller aggregering hos proteiner med hjälp av konjugerade polyelektrolyter |
| JP4392499B2 (ja) * | 2004-12-07 | 2010-01-06 | 国立大学法人 筑波大学 | キラルポリマーの製造方法及びキラルポリマー並びにキラルポリマーの動的な電気化学的方法による光学活性制御 |
| JPWO2007063950A1 (ja) * | 2005-12-01 | 2009-05-07 | 国立大学法人東北大学 | コンフォーメーション病診断および治療用の長波長蛍光物質およびその使用 |
| AU2007212812A1 (en) * | 2006-02-09 | 2007-08-16 | Biochromix Ab | Methods for detection of pathogenic prion proteins associated with prion diseases, using conjugated polyelectrolytes |
| WO2007109545A2 (en) * | 2006-03-16 | 2007-09-27 | The Regents Of The University Of California | Copolymers of alkoxythiophene |
| CA2676214A1 (en) * | 2007-01-22 | 2008-07-31 | Astrazeneca Ab | Novel heteroaryl substituted imidazo [1,2 -a] pyridine derivatives |
| CA2721770A1 (en) | 2007-04-18 | 2008-10-30 | Biochromix Ab | Medical use of conjugated polyelectrolytes |
-
2009
- 2009-10-19 ES ES09820849.9T patent/ES2551744T3/es active Active
- 2009-10-19 CN CN200980151290.7A patent/CN102256959B/zh not_active Expired - Fee Related
- 2009-10-19 KR KR1020117011029A patent/KR101743049B1/ko not_active Expired - Fee Related
- 2009-10-19 EP EP09820849.9A patent/EP2350042B1/en not_active Not-in-force
- 2009-10-19 CA CA2740969A patent/CA2740969C/en not_active Expired - Fee Related
- 2009-10-19 US US13/124,621 patent/US8710246B2/en not_active Expired - Fee Related
- 2009-10-19 WO PCT/SE2009/051188 patent/WO2010044744A1/en not_active Ceased
- 2009-10-19 JP JP2011532044A patent/JP5646495B2/ja not_active Expired - Fee Related
- 2009-10-19 WO PCT/SE2009/051187 patent/WO2010044743A1/en not_active Ceased
- 2009-10-19 BR BRPI0920850A patent/BRPI0920850A2/pt not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012505879A5 (enExample) | ||
| WO2007138472A3 (en) | Triazolopyridazine derivatives | |
| RU2448096C2 (ru) | Диарилгидантоины | |
| NO20085060L (no) | Triazolpyrazinderivater anvendelige som anti-cancermidler | |
| GEP20094723B (en) | Tetraazabenzo [e] azulene derivatives and analogs thereof | |
| WO2006018182A8 (en) | Combinations for the treatment of diseases involving cell proliferation | |
| UY30183A1 (es) | Derivados de quinolina | |
| JP2013510123A5 (enExample) | ||
| TW200607807A (en) | Macrocyclic beta-secretase inhibitors | |
| AR062886A1 (es) | Compuestos de tiazol pirazolopirimidina, composicion farmaceutica que lo comprende y su uso para preparar un medicamento | |
| NO20072515L (no) | 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav | |
| CA2510853A1 (en) | Pyrrolopyrimidine derivatives | |
| US10946020B2 (en) | Compositions and methods for treating cancer | |
| CN101001670B (zh) | 用于睡眠障碍的组合物 | |
| JP6343034B2 (ja) | ナフチリジンジオン誘導体 | |
| MY140630A (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
| FR2903107B1 (fr) | Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique | |
| TW200504029A (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
| AR045914A1 (es) | Compuesto alcoholico terciario del 8-azoniabiciclo [3.2.1] octano, composicion farmaceutica que lo comprende y su uso para preparar esta ultima | |
| CN101600426A (zh) | 用于治疗肠道疾病的异山梨醇单硝酸酯衍生物 | |
| TW200504030A (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
| TNSN05080A1 (en) | NOVEL ANTIMYCOBACTERIAL COMPOUNDS (as filed) AND PYRROLE DERIVATIVES AS ANTIMYCOBACTERIAL COMPOUNDS (as published) | |
| RU2011108485A (ru) | Новые (поли)аминоалкиламиноалкиламидные, алкилмочевинные или алкилсульфонамидные производные эпиподофиллотоксина, способ их получения и их применение в терапии в качестве противораковых средств | |
| BRPI0517412A (pt) | derivados de benzodiazepina substituìdos | |
| WO2006124413A3 (en) | Methods for treating drug resistant cancer |